Na Li

Hospital Medicine

3333 Silas Creek Pkwy
Winston Salem, NC 27103

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 25 publications

Bempedoic Acid and First and Recurrent Limb Outcomes in Statin-Intolerant Patients With Peripheral Artery Disease: Insights From the CLEAR Outcomes Trial.

Bempedoic Acid and First and Recurrent Limb Outcomes in Statin-Intolerant Patients With Peripheral Artery Disease: Insights From the CLEAR Outcomes Trial.

Journal: Circulation

Published: August 18, 2026

Efficacy and Safety of Bempedoic Acid in Patients Aged ≥75 Years Stratified by Varying Statin Exposure: Results From Phase 3 Studies of Bempedoic Acid.

Efficacy and Safety of Bempedoic Acid in Patients Aged ≥75 Years Stratified by Varying Statin Exposure: Results From Phase 3 Studies of Bempedoic Acid.

Journal: Journal of the American Heart Association

Published: June 23, 2026

Factors associated with enhanced LDL cholesterol lowering with bempedoic acid among statin-intolerant patients from CLEAR Outcomes.

Factors associated with enhanced LDL cholesterol lowering with bempedoic acid among statin-intolerant patients from CLEAR Outcomes.

Journal: European journal of preventive cardiology

Published: May 19, 2026

The impact of bempedoic acid on cardiovascular events across the spectrum of kidney function, a CLEAR Outcomes trial secondary analysis.

The impact of bempedoic acid on cardiovascular events across the spectrum of kidney function, a CLEAR Outcomes trial secondary analysis.

Journal: American journal of preventive cardiology

Published: March 08, 2026

Effect of bempedoic acid in the absence of background lipid-lowering therapy on LDL cholesterol, hsCRP, and cardiovascular outcomes, among statin-intolerant patients: a post-hoc analysis of the CLEAR Outcomes trial.

Effect of bempedoic acid in the absence of background lipid-lowering therapy on LDL cholesterol, hsCRP, and cardiovascular outcomes, among statin-intolerant patients: a post-hoc analysis of the CLEAR Outcomes trial.

Journal: European journal of preventive cardiology

Published: January 23, 2026

Association of Uric Acid-Lowering Therapies on Gout Frequency with Bempedoic Acid: Clinical Insights From CLEAR Outcomes.

Association of Uric Acid-Lowering Therapies on Gout Frequency with Bempedoic Acid: Clinical Insights From CLEAR Outcomes.

Journal: JACC. Advances

Published: July 15, 2025

Lack of impact of adjunctive lipid-modifying therapy in the CLEAR Outcomes trial.

Lack of impact of adjunctive lipid-modifying therapy in the CLEAR Outcomes trial.

Journal: Journal of clinical lipidology

Published: July 02, 2025

Sex Differences in Statin Intolerance: Insights From the CLEAR Outcomes Trial.

Sex Differences in Statin Intolerance: Insights From the CLEAR Outcomes Trial.

Journal: Clinical cardiology

Published: April 17, 2025

Characteristics and outcomes of patients with and without statin-associated muscle symptoms treated with bempedoic acid in the CLEAR Outcomes trial.

Characteristics and outcomes of patients with and without statin-associated muscle symptoms treated with bempedoic acid in the CLEAR Outcomes trial.

Journal: Journal of clinical lipidology

Published: November 05, 2024

Impact of the COVID-19 Pandemic on Conduct and Results of CLEAR Outcomes Trial.

Impact of the COVID-19 Pandemic on Conduct and Results of CLEAR Outcomes Trial.

Journal: Clinical cardiology

Published: May 07, 2024

Comparative Cardiovascular Benefits of Bempedoic Acid and Statin Drugs.

Comparative Cardiovascular Benefits of Bempedoic Acid and Statin Drugs.

Journal: Journal of the American College of Cardiology

Published: March 08, 2024

Evaluating the effect of bempedoic acid on kidney function: call for cautious implementation - Authors' reply.

Evaluating the effect of bempedoic acid on kidney function: call for cautious implementation - Authors' reply.

Journal: The lancet. Diabetes & endocrinology

Published: February 08, 2024

Showing 1-12 of 25

Last Updated: 09/26/2026